NCT01289080

Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects

A Single-dose, Open-label, Parallel-group, Matched Trial Evaluating the Pharmacokinetics of Oral OPC-34712 Tablets in Subjects With Normal Renal Function and Renally Impaired Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This trial is an open-label, multi-center, parallel-arm, single-dose trial in 2 groups: 1 group of subjects with normal renal function and 1 group of severely renally impaired subjects.

Conditions

• Schizophrenia
• Psychiatric Disorders

Interventions

Type	Name	Description
DRUG	OPC-34712	administered orally

Timeline

• Start date: 2011-01-01
• Primary completion: 2011-12-01
• Completion: 2012-01-01
• First posted: 2011-02-03
• Last updated: 2015-10-29
• Results posted: 2015-10-29

Locations

2 sites across 1 country: United States